Lexicon Pharmaceuticals
LXRX
#6600
Rank
C$1.18 B
Marketcap
C$2.66
Share price
5.90%
Change (1 day)
33.56%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): C-$0.92

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.21. In 2022 the company made an earnings per share (EPS) of C-$0.86 an increase over its 2021 EPS that were of C-$0.86.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$0.926.52%
2022C-$0.86-0%
2021C-$0.8610.91%
2020C-$0.78-145.08%
2019C$1.72-206.09%
2018C-$1.62-5.74%
2017C-$1.72-10.95%
2016C-$1.932640%
2015C-$0.07060-96.34%
2014C-$1.93-2.53%
2013C-$1.98-9.09%
2012C-$2.17-37.14%
2011C-$3.460%
2010C-$3.46-39.66%
2009C-$5.733.57%
2008C-$5.53-8.2%
2007C-$6.03-24.69%
2006C-$8.0142.11%
2005C-$5.63-22.97%
2004C-$7.31-35.09%
2003C-$11.27-0%
2002C-$11.2762.86%
2001C-$6.92-19.54%
2000C-$8.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$26.81-12,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$8.32-4,026.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.17-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.25 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$14.13-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02824-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.06 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$41.35 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA